Bank of America’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.54M | Sell |
270,121
-4,870
| -2% | -$99.9K | ﹤0.01% | 3226 |
|
|
2025
Q1 | $5.63M | Buy |
274,991
+64,203
| +30% | +$1.32M | ﹤0.01% | 3118 |
|
|
2024
Q4 | $4.77M | Sell |
210,788
-117,607
| -36% | -$2.66M | ﹤0.01% | 3075 |
|
|
2024
Q3 | $8.08M | Buy |
328,395
+17,962
| +6% | +$442K | ﹤0.01% | 2783 |
|
|
2024
Q2 | $7.18M | Buy |
310,433
+44,514
| +17% | +$1.03M | ﹤0.01% | 2816 |
|
|
2024
Q1 | $6.4M | Buy |
265,919
+85,727
| +48% | +$2.06M | ﹤0.01% | 2887 |
|
|
2023
Q4 | $4.15M | Buy |
180,192
+40,012
| +29% | +$921K | ﹤0.01% | 3068 |
|
|
2023
Q3 | $2.85M | Sell |
140,180
-135,398
| -49% | -$2.76M | ﹤0.01% | 3283 |
|
|
2023
Q2 | $6.44M | Buy |
275,578
+34,865
| +14% | +$814K | ﹤0.01% | 2670 |
|
|
2023
Q1 | $5.6M | Buy |
240,713
+52,838
| +28% | +$1.23M | ﹤0.01% | 2924 |
|
|
2022
Q4 | $4.73M | Buy |
187,875
+62,759
| +50% | +$1.58M | ﹤0.01% | 2940 |
|
|
2022
Q3 | $3.3M | Sell |
125,116
-24,725
| -17% | -$653K | ﹤0.01% | 3217 |
|
|
2022
Q2 | $4.33M | Sell |
149,841
-203,149
| -58% | -$5.87M | ﹤0.01% | 3064 |
|
|
2022
Q1 | $12.2M | Buy |
352,990
+131,409
| +59% | +$4.53M | ﹤0.01% | 2318 |
|
|
2021
Q4 | $9.71M | Sell |
221,581
-95,934
| -30% | -$4.2M | ﹤0.01% | 2536 |
|
|
2021
Q3 | $16.1M | Buy |
317,515
+190,855
| +151% | +$9.68M | ﹤0.01% | 2056 |
|
|
2021
Q2 | $6.59M | Sell |
126,660
-7,524
| -6% | -$391K | ﹤0.01% | 2820 |
|
|
2021
Q1 | $6.13M | Buy |
134,184
+56,152
| +72% | +$2.57M | ﹤0.01% | 2827 |
|
|
2020
Q4 | $3.58M | Buy |
78,032
+50,842
| +187% | +$2.34M | ﹤0.01% | 2973 |
|
|
2020
Q3 | $1.06M | Buy |
27,190
+21,859
| +410% | +$851K | ﹤0.01% | 3662 |
|
|
2020
Q2 | $202K | Buy |
5,331
+4,331
| +433% | +$164K | ﹤0.01% | 4698 |
|
|
2020
Q1 | $27K | Buy |
+1,000
| New | +$27K | ﹤0.01% | 5470 |
|